• Xometry, Inc. recently reported its second-quarter 2026 results, with sales rising to US$229.28 million and net loss narrowing to US$5.31 million, while also providing third-quarter revenue guidance of US$234 million to US$236 million.
• The company raised its full-year 2026 revenue growth outlook to 33%–34%, underpinned by higher expected marketplace expansion of about 37%, signaling management confidence in its AI-powered manufacturing platform.
• With Xometry lifting full-year revenue guidance, we'll examine how this stronger growth outlook shapes the company's investment narrative.

Invest in the nuclear renaissance through our list of 89 elite nuclear energy infrastructure plays powering the global AI revolution.

What Is Xometry's Investment Narrative?

To own Xometry, you have to believe its AI-enabled marketplace can keep pulling more custom manufacturing online while steadily closing the gap to profitability. The latest quarter helps that story: revenue accelerated to US$229.28 million, losses narrowed sharply, and management raised both Q3 and full-year 2026 growth guidance, pointing to stronger marketplace demand than previously expected. In the near term, the main catalysts now look like sustained high growth alongside continued loss reduction and proof that the Siemens partnership can deepen enterprise adoption. At the same time, the stock already reflects very large multi‑year returns, trades on a rich sales multiple, and sits in the hands of a relatively new management team, so expectations feel higher after this guidance upgrade rather than safer.

However, one key business risk here is easy to underestimate and investors should understand it. Xometry's shares have been on the rise but are still potentially undervalued by 19%. Find out what it's worth.

Exploring Other Perspectives

Five Simply Wall St Community fair values span roughly US$32 to US$114, showing wide disagreement on Xometry’s worth. Set against management’s upgraded growth guidance, that spread underlines why it helps to compare different views before deciding how much optimism you want to price in.

Explore 5 other fair value estimates on Xometry - why the stock might be worth less than half the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Xometry research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Xometry research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Xometry's overall financial health at a glance.

Interested In Other Possibilities?

Every day counts. These free picks are already gaining attention. See them before the crowd does:

• Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 28 best rare earth metal stocks of the very few that mine this essential strategic resource.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.